ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

VRTX34 Vertex Pharmaceuticals Inc

596.24
22.04 (3.84%)
May 31 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.25B2.34B2.3B2.37B2.5B2.48B2.57B2.69B
Operating Income 1.11B1.13B1.03B777.1M1.03B1.04B988.5M1.14B
Pre Tax Income 1.02B1.18B1.08B891.5M1.16B1.18B1.1B1.28B
Net Income 810.5M930.5M818.9M699.8M915.7M1.04B919.6M1.1B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 1.03B1.18B994.5M778.4M1.03B1.02B963.1M1.11B
EBITDA 1.14B1.16B1.07B815.9M1.07B1.08B1.05B1.19B
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.7B2.49B3.05B4.16B6.21B7.58B8.99B9.92B
Operating Income 9.94M123.24M635.15M1.2B2.86B2.78B4.31B3.83B
Pre Tax Income -67.37M-15.69M600.24M1.39B3.12B2.73B4.23B4.33B
Net Income -112.05M263.48M2.1B1.18B2.71B2.34B3.32B3.57B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.4511.048.2184.54410.4349.20412.92513.856
EBIT 9.94M41.86M634.36M1.26B2.98B2.79B4.32B3.79B
EBITDA 71.33M441.93M736.57M1.3B2.97B2.91B4.46B4.01B